• Thurs news: Amgen reaps Horizon buyout rewards in Q3. Baxter exits China IV market. Big Pharma earnings. Novo takes steps to end shortages. Roche Alzheimer’s test. See more on our front page


Amgen piles $2B more into pharma's ADC rush in Synaffix pact

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 05, 2023 at 04:52: PM
via A day after buzzing Hummingbird Bioscience for an antibody-drug conjugate licensing pact, Synaffix is back with a substantially similar, yet bigger deal. The Amsterdam-headquartered biotech will work with Amgen in a pact valued at up to $2 billion.

article source
 




Top Bottom
Back
Quote